TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3541653

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 31959609

Group type: EXPERIMENTAL
Intervention: HEV vaccine (HEV 239, Hecolin)
Number of subjects: 20000

Group type: COMPARATOR
Intervention: Control vaccine (hepatitis B vaccine)
Number of subjects: 20000
Study: 31498799

Group type: EXPERIMENTAL
Intervention: FREE approach (intervention)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Usual GP care (control)
Number of subjects: 226
Study: 29215606

Group type: EXPERIMENTAL
Intervention: Nutrient enriched breakfast bar (containing α‐Linolenic acid, l‐tyrosine, l‐theanine, vitamins, minerals and 21.5 mg of caffeine)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Isocaloric, macronutrient matched control bar
Number of subjects: 95
Study: 25746294

Group type: EXPERIMENTAL
Intervention: 21/7‐active COC (DSG/EE+7 days EE)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: 24 days of 3mg drospirenone (DRSP)/20 mcg EE, followed by 4 placebo (PBO)‐pill days (DRSP/EE+4 days PBO)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: 21 days of 100 mcg levonorgestrel (LNG)/20 mcg EE, followed by 7 PBO‐pill days (LNG/EE+7 days PBO)
Number of subjects: 146
Study: 23798067

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 60
Study: 21453379

Group type: EXPERIMENTAL
Intervention: Adapted U.S. model of pharmaceutical care (n=128)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Usual care (control; n=125)
Number of subjects: 253
Study: 19147637

Group type: EXPERIMENTAL
Intervention: Proactive individualised telephone based peer support
Number of subjects: 701

Group type: COMPARATOR
Intervention: Control group (no peer support)
Number of subjects: 701
Study: 16766243

Group type: EXPERIMENTAL
Intervention: 8-hour intervention using experiential and conceptual change educational approaches
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Participant group
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 48
Study: 15327342

Group type: EXPERIMENTAL
Intervention: Group singing (nine 30-minute sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Listening to music while exercising (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group singing
Number of subjects: 0
Study: 11416745

Group type: EXPERIMENTAL
Intervention: 200 ml milk before exercise SPECT and after injection for rest SPECT acquisition (Group B) plus a standard solid and fluid meal
Number of subjects: 81

Group type: COMPARATOR
Intervention: 200 ml milk before exercise SPECT and after injection for rest SPECT acquisition (Group A)
Number of subjects: 81
Study: 9250226

Group type: EXPERIMENTAL
Intervention: Reminder letter for mammogram or Pap smear
Number of subjects: 7077

Group type: EXPERIMENTAL
Intervention: Reminder letter and reminder placed in medical chart
Number of subjects: 7077

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 7077
Study: 8440858

Group type: EXPERIMENTAL
Intervention: Physical therapy sessions three times weekly for 4 months, lasting 30 minutes each, consisting of functional activity and general conditioning exercises tailored to individual needs.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical therapy sessions three times weekly for 4 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Structured social visits three times weekly to control for potential Hawthorne effects.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Physical therapy intervention costs and incremental health care utilization.
Number of subjects: 0
Study: 3822279

Group type: EXPERIMENTAL
Intervention: 0.75% lidocaine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 53
Study: 29616280

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (CRS)
Number of subjects: 0
Study: 26730451

Group type: EXPERIMENTAL
Intervention: CERAMIC
Number of subjects: 92

Group type: COMPARATOR
Intervention: POLYETHYLENE
Number of subjects: 92
Study: 24956971

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (12.5-25 mg daily, group D)
Number of subjects: 2409

Group type: COMPARATOR
Intervention: Other antihypertensive medications (group A)
Number of subjects: 2409

Group type: EXPERIMENTAL
Intervention: Chlorthalidone (group D)
Number of subjects: 2409
Study: 23276189

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet (MED) for 4 months
Number of subjects: 129

Group type: COMPARATOR
Intervention: USDA MyPyramid diet for Pregnancy and Breastfeeding (comparison diet)
Number of subjects: 129
Study: 21545300

Group type: EXPERIMENTAL
Intervention: Acid etching
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Composite resin adhesives
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: No etch + bracket
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Sealed side of teeth
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Unsealed side of teeth
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Brackets
Number of subjects: 150
Study: 18085739

Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography (TEE)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Transthoracic echocardiography (TTE)
Number of subjects: 81
Study: 16487390

Group type: EXPERIMENTAL
Intervention: Active medication (ranitidine plus cisapride)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Infant mental health consultation (IMHC)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 103
Study: 12871446

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg daily subcutaneous injections
Number of subjects: 85

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Enoxaparin in primary aborters (women with no previous live births)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Enoxaparin in patients with five or more miscarriages
Number of subjects: 85
Study: 10831196

Group type: EXPERIMENTAL
Intervention: Lidocaine 4% solution
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%)
Number of subjects: 16
Study: 8018455

Group type: EXPERIMENTAL
Intervention: 0.04 mg kg‐1 enalaprilat (low‐dose, n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.08 mg kg‐1 enalaprilat (high‐dose, n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline solution as placebo (control group, n = 10)
Number of subjects: 30
Study: 2659203

Group type: EXPERIMENTAL
Intervention: 3% topical minoxidil
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 4582051

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 30747745

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate administration for longer than 18 hours, given within 12 hours of delivery, maintaining a maternal serum level of 4.1 mg/dl.
Number of subjects: 0
Study: 28316258

Group type: EXPERIMENTAL
Intervention: Walking football
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 0
Study: 25716210

Group type: EXPERIMENTAL
Intervention: Initial rhythm of ventricular fibrillation/ventricular tachycardia (VF/VT)
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Survival with good neurologic outcome
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Initial rhythm of VF/VT (exploratory secondary analysis)
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Survival with good neurologic outcome (exploratory secondary analysis)
Number of subjects: 1655
Study: 25417403

Group type: EXPERIMENTAL
Intervention: Fuzi-cake-separated moxibustion at Guanyuan (CV 4) and Zhongji (CV 3), 20 min twice a day for 3 days before operation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no fuzi-cake-separated moxibustion)
Number of subjects: 60
Study: 20882268

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 674

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 674
Study: 19243424

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate 1,200 mg
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate 800 mg
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate 400 mg
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 17307536

Group type: EXPERIMENTAL
Intervention: Early inhaled nitric oxide (iNO) therapy
Number of subjects: 299

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 299
Study: 15338492

Group type: EXPERIMENTAL
Intervention: Pamidronate 45 mg
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 11170945

Group type: EXPERIMENTAL
Intervention: Clinafloxacin (200 mg every 12 h)
Number of subjects: 541

Group type: COMPARATOR
Intervention: Imipenem (500 mg every 6 h)
Number of subjects: 541
Study: 9824573

Group type: EXPERIMENTAL
Intervention: MCT + LCT (medium chain triglycerides and long chain triglycerides)
Number of subjects: 19

Group type: COMPARATOR
Intervention: LCT (long chain triglycerides) alone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: MCT + LCT
Number of subjects: 19
Study: 8824654

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg q.d.s.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg b.d.
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg q.d.s.
Number of subjects: 7
Study: 2382874

Group type: EXPERIMENTAL
Intervention: Adenosine inhalation tests on day A
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline inhalation test on day B
Number of subjects: 8

Group type: COMPARATOR
Intervention: Methacholine inhalation tests on day C
Number of subjects: 8
Study: 7362945

Group type: EXPERIMENTAL
Intervention: Prophylactic clindamycin, 150 mg 6-hourly for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wounds treated after 4 h
Number of subjects: 0

Group type: COMPARATOR
Intervention: All wounds treated within 4 h
Number of subjects: 0
Study: 31706052

Group type: EXPERIMENTAL
Intervention: Alendronate (70 mg weekly) + daily elemental calcium (500 mg) + cholecalciferol (1000 IU)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (daily elemental calcium (500 mg) + cholecalciferol (1000 IU) only)
Number of subjects: 107
Study: 31050056

Group type: EXPERIMENTAL
Intervention: Adductor Strengthening Programme
Number of subjects: 501
Study: 28177751

Group type: EXPERIMENTAL
Intervention: Isokinetic fatigue group (n = 15) with 10 sets of 20 repetitions of maximal isokinetic knee extensor contractions at 300°·s‐1
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Isometric fatigue group (n = 15) with 10 repetitions of 6‐s knee extensor MVIC
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (n = 12) were not fatigued
Number of subjects: 42
Study: 24930949

Group type: EXPERIMENTAL
Intervention: GreenLight™ Simulator training (novice group: 12 participants, 10 sessions of subtask training modules followed by a long operative case)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: GreenLight™ Simulator training (intermediate and expert groups: 14 and 7 participants respectively, performed all training modules once followed by one operative case)
Number of subjects: 46
Study: 24174677

Group type: EXPERIMENTAL
Intervention: Dynamic face presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Static face presentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Connections modulated by dynamic and static fear from amygdala
Number of subjects: 0
Study: 21836511

Group type: EXPERIMENTAL
Intervention: sirolimus, mycophenolate mofetil and steroids
Number of subjects: 15
Study: 19680260

Group type: EXPERIMENTAL
Intervention: Azelnidipine (first-line therapy)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Azelnidipine (converted from amlodipine)
Number of subjects: 232
Study: 17554712

Group type: EXPERIMENTAL
Intervention: Zidovudine-lamivudine
Number of subjects: 213

Group type: COMPARATOR
Intervention: Stavudine-didanosine
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 213

Group type: COMPARATOR
Intervention: Nelfinavir
Number of subjects: 213
Study: 15756168

Group type: EXPERIMENTAL
Intervention: Quadriceps tendon (QT group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Patellar tendon (PT group)
Number of subjects: 48
Study: 11159250

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.125% bupivacaine with clonidine 1 microg/mL and sufentanil 0.1 microg/mL at 10 mL/h (Group 1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PCA boluses of 10 mL/h of 0.125% bupivacaine with clonidine 1 microg/mL and sufentanil 0.1 microg/mL (Group 2)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: PCA boluses of 5 mL per 30 min of 0.125% bupivacaine with clonidine 1 microg/mL and sufentanil 0.1 microg/mL (Group 3)
Number of subjects: 45
Study: 9626725

Group type: EXPERIMENTAL
Intervention: Collaborative management programme including patient education, on-site mental health treatment, adjustment of antidepressant medication, behavioural activation and monitoring of medication adherence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 8049826

Group type: EXPERIMENTAL
Intervention: Ozone (O3) alone
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ozone (O3) + Sulfuric acid (H2SO4)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Sulfuric acid (H2SO4) alone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 45
Study: 3355357

Group type: EXPERIMENTAL
Intervention: Exercise (EN, n = 18) and Exercise with light weights (EW, n = 17)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Nonexercising controls (C, n = 12)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Exercise (EN, n = 18)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Exercise with light weights (EW, n = 17)
Number of subjects: 47
Study: 31419002

Group type: EXPERIMENTAL
Intervention: Corticocancellous FDBA blocks
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Cancellous FDBA blocks
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study: 28606499

Group type: EXPERIMENTAL
Intervention: Functional somatic syndromes (FSS) patients
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Functional somatic syndromes (FSS) patients with mild SSS
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Functional somatic syndromes (FSS) patients with moderate SSS
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Functional somatic syndromes (FSS) patients with severe SSS
Number of subjects: 273
Study: 25875753

Group type: COMPARATOR
Intervention: Endoscopic sphincterotomy (EST)
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy plus endoscopic papillary balloon dilation (EST-EPBD)
Number of subjects: 291
Study: 23970363

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 21

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 21
Study: 21969666

Group type: EXPERIMENTAL
Intervention: High-pitch spiral scanning in group A
Number of subjects: 272

Group type: COMPARATOR
Intervention: Sequential scanning in group A
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Sequential scanning in group B
Number of subjects: 272

Group type: COMPARATOR
Intervention: Retrospective spiral scanning in group B
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Narrow-window prospective sequential scanning in group A
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Wide-window prospective sequential scanning in group B
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: High-pitch spiral scanning in subpopulation (<55 beats per minute)
Number of subjects: 272
Study: 18847416

Group type: EXPERIMENTAL
Intervention: New immunosuppressive drugs (specific drugs not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcineurin inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose or calcineurin inhibitor-free regimens
Number of subjects: 0
Study: 16314018

Group type: EXPERIMENTAL
Intervention: Rhythmic Movement Test (RMT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Omission of sensory information
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Errors in time
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Errors in space
Number of subjects: 36
Study: 14568898

Group type: EXPERIMENTAL
Intervention: ACD+ITD CPR
Number of subjects: 210

Group type: COMPARATOR
Intervention: S-CPR
Number of subjects: 210
Study: 10908942

Group type: EXPERIMENTAL
Intervention: Light mobilization program with information and advice to stay active
Number of subjects: 457

Group type: COMPARATOR
Intervention: Conventional primary health care (control group)
Number of subjects: 457
Study: 8958267

Group type: EXPERIMENTAL
Intervention: Steroid withdrawal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard immunosuppression (cyclosporine and steroids)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 10(‐7) M prednisolone in vitro
Number of subjects: 0
Study: 1540881

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with 5‐fluorouracil (5‐FU), doxorubicin, and mitomycin C (FAM)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Sequential chemotherapy with mitomycin C, followed by doxorubicin on disease progression, followed by 5‐FU
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Secondary therapy with doxorubicin alone
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Tertiary therapy with 5‐FU alone
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy (FAM)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Sequential chemotherapy
Number of subjects: 142
Study: 3904899

Group type: EXPERIMENTAL
Intervention: Omnipaque
Number of subjects: 49

Group type: COMPARATOR
Intervention: Urografin
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both Omnipaque and Urografin
Number of subjects: 49
Study: 30738701

Group type: EXPERIMENTAL
Intervention: Compression stocking on one leg during a three-hour flight
Number of subjects: 34
Study: 29767420

Group type: EXPERIMENTAL
Intervention: Laser peripheral iridotomy (LPI)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 39
Study: 26093535

Group type: EXPERIMENTAL
Intervention: High-dose green tea extract (EGCG) at a daily dosage of 856.8 mg
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: High-dose green tea extract (EGCG)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 24925303

Group type: EXPERIMENTAL
Intervention: Galacto‐oligosaccharides (GOS) (2·5 g; three times per d) during and 7 d after AMX treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (maltodextrin, n 6) (2·5 g; three times per d) during and 7 d after AMX treatment
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GOS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 22861655

Group type: EXPERIMENTAL
Intervention: Sleep quality during the last week
Number of subjects: 411

Group type: COMPARATOR
Intervention: Sleep quality preadmission
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Patients with previous hospitalization and operation experience
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Patients who underwent a major surgical procedure
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Patients hospitalized for a week
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Patients undergoing medical intervention during sleeping hours
Number of subjects: 411

Group type: EXPERIMENTAL
Intervention: Patients with chronic illness history and postponed operations
Number of subjects: 411
Study: 21137666

Group type: EXPERIMENTAL
Intervention: Catheter removal after 1 day
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Catheter removal after 2 days
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Catheter removal after 4 days
Number of subjects: 189
Study: 17980217

Group type: EXPERIMENTAL
Intervention: Aerobic exercise
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Aerobic exercise and weight loss
Number of subjects: 133

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 133
Study: 15109358

Group type: EXPERIMENTAL
Intervention: Real electroacupuncture (phase I)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham electroacupuncture (phase II)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Real electroacupuncture (phase II)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham electroacupuncture (phase I)
Number of subjects: 40
Study: 12006310

Group type: EXPERIMENTAL
Intervention: Falls nurse intervention
Number of subjects: 348

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 348
Study: 9653595

Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg t.i.d.
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study: 8131533

Group type: COMPARATOR
Intervention: Room Air (RA)
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Oxygen (O2, 6 L/min by nasal cannula)
Number of subjects: 276
Study: 2480147

Group type: COMPARATOR
Intervention: Iloprost (1 ng/kg/body weight for 45 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Iloprost (2 ng/kg/body weight for 45 min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Iloprost (4 ng/kg/body weight for 45 min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Placebo (saline infusion for 45 min)
Number of subjects: 8
Study: 30446246

Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin before primary angioplasty (AST)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard treatment alone (ST)
Number of subjects: 103
Study: 25731907

Group type: EXPERIMENTAL
Intervention: Cogmed working memory training (CWMT)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Behavioral parent training (BPT)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Combined treatment (CWMT and BPT)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Active control (placebo)
Number of subjects: 91